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ObituaryLeena Peltonen, one of the leading 
lights of the human genetics research 
community, passed away on March 11, 
2010 at her home in Finland. Leena was 
born in Oulu, Finland, a town of approxi-
mately 100,000 people about 700 km 
north of Helsinki, in 1952. Her father was 
a civil servant and subsequently rector 
of the business school and her mother a 
teacher. She had one brother who devel-
oped type 1 diabetes from which he later 
died of complications. Leena recounted 
that this early intimate encounter 
with disease kindled her enthusi-
asm for medical research.
Leena graduated from high 
school top in her class, character-
izing herself with typical self-depre-
cating humor as “a swot” (slang for 
an overzealous student), and pro-
ceeded to study medicine in Oulu. 
Following graduation, she obtained 
her first taste of research study-
ing inherited collagen disorders, a 
subject that was an abiding interest 
for many years. Between 1978 and 
1980 she undertook the first of sev-
eral interludes of work outside Fin-
land, a period of postdoctoral study 
at Rutgers University, New Jersey, 
where she attempted to character-
ize mutations in the inherited bone 
disease osteogenesis imperfecta 
through protein analysis. Trans-
planted from the relative quiet of 
provincial Finnish life into the pen-
umbra of a great metropolis, she 
and her husband Aarno sampled 
with relish the nearby cultural riches 
of Manhattan, visiting the ballet and 
opera on 100 occasions within the 
space of 18 months. Leena then 
returned to Finland to continue work 
on connective tissue disorders, begin-
ning to develop and apply the newly 
invented suite of recombinant DNA tech-
nologies to identify human inherited dis-
ease genes.
The Finnish population has an unusual 
history, developing from a small number 
of individuals who migrated in two major 
waves 4000 and 2000 years ago (from 
the South and the East) and who subse-
quently remained relatively isolated. As 
a consequence of this founder effect, 
certain inherited diseases that are rare 
in most outbred populations turn out 
by chance to be relatively common in 
Finland, whereas others such as cystic 
fibrosis and phenylketonuria are rela-
tively rare.
In 1985, Leena embarked on a highly 
fruitful and influential period of research 
studying the approximately 30 rare 
recessive diseases that are particularly 
common in Finland. Using genetic link-
age analysis and positional cloning, her 
group identified the underlying genes 
for 15 of these diseases, including 
those for autoimmune recessive endo-
crinopathy, Meckel syndrome, several 
lysosomal storage diseases, and neu-
ronal ceroid lipofuscinosis. She further 
elaborated this strategy by implement-
ing the approach known as homozy-
gosity mapping, which depends on 
consanguinity of parents of individu-
als with recessive diseases, using it 
to identify the gene responsible for 
infantile onset spinocerebellar ataxia. 
In 1998, she moved to the University of 
California Los Angeles (UCLA) where 
she spent 4 years establishing a major 
genetic research center.
Following this successful decade 
of research that established her as a 
scientist of international repute, Leena 
then attempted to further exploit the 
population structure of Finland to iden-
tify the genes for more common dis-
eases using linkage analysis and posi-
tional cloning. This phase of study 
resulted in the identification of 
genes for familial hyperlipidemia 
and lactose intolerance.
In recent years, Leena began to 
use the fruits of the human genome 
sequence and HapMap projects, 
embarking on genome-wide asso-
ciation studies (GWAS) to iden-
tify low-penetrance susceptibility 
alleles. This period coincided with 
further stays abroad, notably at the 
Broad Institute of MIT and Harvard, 
where she became a much-loved 
member of the Medical and Popula-
tion Genetics Program. These stud-
ies were predominantly focused on 
cohorts of normal individuals, many 
from Finland, in whom multiple quan-
titative traits, for example lipid lev-
els, were systematically measured 
and represented the culmination of 
long years of data and sample col-
lection. The National Public Health 
Institute of Finland had responsibil-
ity for monitoring the health of the 
Finnish population through epi-
demiological surveys. Starting in 
the late eighties, Leena forcefully 
encouraged the collection of sam-
ples for DNA extraction alongside 
accumulation of epidemiological data 
such that by the time the GWAS era 
arrived, hundreds of thousands of indi-
viduals who had been assiduously moni-
tored for disease incidence had donated 
DNA samples. Leena’s were among the 
first cohorts to be subjected to GWAS, 
research that resulted in the identifica-
tion of genetic loci influencing lipid levels 
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and other quantitative traits. In large part 
as a result of her efforts, approximately 
40,000 Finns have now been genotyped 
for hundreds of thousands of single-
nucleotide polymorphisms, about 1% of 
the Finnish population.
Leena had a clear view of what was 
coming next. She joined the Wellcome 
Trust Sanger Institute in 2007, participat-
ing in the 1000 genomes project, energet-
ically recruiting many new human genet-
ics faculty, and beginning preparations 
for large-scale sequencing as the next 
step in the discovery of DNA variation 
implicated in disease susceptibility. She 
was co-PI on a large project to sequence 
10,000 individuals from the UK that is just 
about to commence and was busily mak-
ing plans for the application of large-scale 
resequencing to isolated European popu-
lations, in particular the Finns.
Leena was a celebrated and frequently 
spotted character on the scientific cir-
cuit. She was known for her warmth and 
flamboyant charm, for her distinctive and 
forceful voice, and for her bluntness, 
the latter trait one that she candidly and 
proudly attributed to her Finnish heritage. 
It was a mistake to underestimate her 
determination. She glued together large 
scientific consortia, which have become 
a signature of genetics in the last decade, 
through her intelligence, passion, force of 
character, charm, and where necessary, 
sharpness in the tackle.
Leena had a deep commitment to 
encouraging younger scientists, in par-
ticular women. She supervised over 70 PhD students and was vocal in scientific 
and national public forums concerning 
education and science policy. Her will 
to combine scientific career success 
with family was an inspiration for many 
younger scientists.
Leena received many marks of recog-
nition during her career. Among these, 
she was a Member of the National Acad-
emy of Sciences of the USA and an Aca-
demician of Finland, one of 12 Acade-
micians in post at any moment in time, 
a position held for life and the highest 
mark of scientific success in Finland.
She had a passion for life, science, and 
friendship. A chilled bottle of champagne 
was always at the ready in the event that 
a cause for celebration arose. Known for 
her striking dress sense, Leena loved 
the hubbub of parties with friends and 
was not averse to a spot of glamour, fre-
quently and fondly recollecting a dinner 
at which she sat between Tom Cruise 
and Gregory Peck. She also. however, 
savored quiet private moments, curled 
up on the sofa at her farmhouse on an 
island in the Finnish archipelago with her 
family around her.
She met her husband, Aarno Palotie, in 
1976 during a microscopy lesson in which 
he was one of a class of medical students 
and Leena was the anatomy demonstra-
tor. Leena asked who could see mito-
chondria and Aarno hotly retorted that you 
could not possibly see them using a light 
microscope. The romantic spark kindled 
by this moment was sustained through-
out their life together during which they Cell were inseparable in work, travel, leisure, 
and the upbringing of their children Laura, 
now a journalist, and Kristian, a student.
Leena was diagnosed as having an 
osteosarcoma in 2008. Over the sub-
sequent 18 months the cancer became 
widely metastatic. Her profound belief 
in the scientific method and modern 
genetics and genomics led her to invite 
a team of scientists to apply the most 
up-to-date strategies for disease moni-
toring and therapy. She insisted on addi-
tional painful surgery in order to obtain 
samples from which cell lines and xeno-
grafts were cultured and the genome of 
her cancer was sequenced. As it sadly 
became clear that these efforts were not 
helping her own case, Leena instructed 
that work continue in this vein on her 
cancer as the model of an approach that 
would ultimately benefit others.
Leena was literally a household name 
in Finland. She was frequently on national 
television promoting science and the role 
of the Finnish heritage and expounding 
strongly held views on education. She 
was a fierce proponent of women fulfill-
ing their career ambitions and having a 
full family life. Two days before she died, 
Finland marked International Women’s 
year by releasing postage stamps honor-
ing six notable Finnish women, of whom 
Leena was one. Her death was the main 
front-page feature of Finnish newspa-
pers and the first item of the day’s televi-
sion news broadcasts.
At Leena’s funeral, a leopard-skin sti-
letto shoe was placed on her coffin.
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